Horton Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Horton Capital Management LLC
CRD #300195
SEC #801-118034
CIK #0001575444
AUM
Employees 3 (100% Investors, 67% Brokers)
Fees
Minimum
Phone215-399-5417
Address1717 Arch St, Suite 3920
Philadelphia, PA 19103
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
1209672482402010201520212027
Fees and Compensation — Form ADV Part 2A (3/29/2021) [Brochure]
Item 5            Fees and Compensation

Management Fee
Advisory clients pay a quarterly advisory fee. Funds are billed each quarter in advance in an amount up to
0.50%  (2%  annualized)  of  the  value  of  the  assets  under  management  as  of  the  first  calendar  day  of  such
quarter. Fund fees are deducted from fund assets.
Separately managed accounts are billed each quarter in an amount up to 0.50% (2% annualized) of the value
of the assets under management. Accounts are typically billed in advance, as of the first calendar day of such
quarter; however, both the fee rate and timing of billing (advance/arrears) may be negotiable at Horton’s
discretion.  Separately  managed  account  fees  are  invoiced  to  clients  and  not  deducted  from  separately
managed account assets.
To the extent that an investor withdraws all or a portion of their investment prior to the end of a quarter, the
investor’s account will be credited back any remaining prepaid management fee not earned by Horton.
Horton reserves the right to reduce or waive the advisory fee for or with respect to any calendar quarter or
part thereof; provided, however, that any such reduction or waiver shall not preclude Horton from increasing
or  reinstituting  the  fee  (but  not  in  excess  of  the  amount  negotiated)  at  such  later  time  as  the  Portfolio
Manager shall deem appropriate.
Additionally, all clients incur brokerage expenses, as discussed further in Item 12.

                                                                                                             4 | P a g e

Brochure Supplement

Horton Capital Management, LLC

Incentive Fee
As discussed below under Item 6, Horton may be entitled to receive from clients a performance allocation of
not more than twenty percent (20%) of any net profit earned, subject to a “high water mark” and, in some
cases, a hurdle rate. This performance allocation reduces returns to clients and, depending upon the rate of
return  earned  on  behalf  of  clients,  it  may  constitute  a  higher  total  fee  than  is  found  in  other  investment
alternatives. The performance allocation may encourage more speculative investments and risk‐taking than
would otherwise be the case. Details regarding incentive fees for a particular engagement may be found in
the offering documents governing Funds and the investment management agreement governing a separately
managed  account.  These  should  be  read  carefully  and  understood  by  prospective  investors  prior  to
committing funds.

Private Fund Expenses
The Funds shall pay all operating expenses not borne by Horton or HCP. Partnership expenses include costs
of borrowing money, legal, audit and accounting fees, insurance premiums, regulatory filing fees, custodial
and  other  fees,  investment  banking  fees,  commissions,  and  any  other  expenses  directly  related  to  the
purchase and sale of securities by or on behalf of a Fund and such other expenses as are to be borne by a
Fund  pursuant  to  the  Partnership  Agreement.  In  addition,  the  Funds  may  pay,  or  reimburse  HCP,  Horton
and/or the Principals for costs and expenses reasonably related to the management of a Fund or its assets.
Details  regarding  the  treatment  of  expenses  for  each  Partnership  are  detailed  in  the  limited  partnership
agreement. All Fund offering documents should be read carefully and understood by prospective investors
prior to committing funds.

Other Terms
Horton, in its sole discretion, may enter into agreements (“Side Letters”) with certain large or strategic Fund
investors  where  Horton  may  waive  or  reduce  management  and  performance  fees  and/or  otherwise  grant
more favorable terms which are not extended to other clients.
Account Minimums and Types of Clients — Form ADV Part 2A (3/29/2021) [Brochure]
Item 7           Types of Clients

Our  clients  are  high  net  worth  individuals,  institutional  investors  and  private  investment  partnerships
investing primarily in under‐covered, small‐ and micro‐cap securities. Horton generally requires investors in
the Horton Capital Partners Fund, LP to invest a minimum initial subscription of $250,000 and investors in the
Horton Freedom Fund, LP to invest a minimum initial subscription of $100,000, although investments for a
lesser amount may be accepted at our discretion. Separately managed accounts typically require an initial
investment  of  $500,000,  although  investments  for  a  lesser  amount  may  be  accepted  at  our  discretion.
Investors  in  the  Funds  are  required  to  qualify  as  accredited  investors  (as  defined  in  Section  501  of  the
Securities Act of 1933) and qualified clients (as defined under Rule 205‐3 of the Investment Advisers Act of
1940). Separately managed account clients are required to qualify as accredited investors, qualified clients
and  qualified  purchasers  (as  defined  in  Section  2  of  the  Investment  Company  Act  of  1940).  In  order  to
participate  in  certain  transactions,  separately  managed  account  clients  also  may  be  required  to  qualify  as
qualified institutional buyers (as defined under Rule 144A of the Securities Exchange Act of 1934).
Sector Form 13F Holdings Value ($M)
Repro MED Systems Inc 32.4
UroGen Pharma Ltd 6.7
 
 
 
 
 
 
 
 
 
Holdings by Sector ($M)
14011284562802020202120222023
Type Form D Funds Date Sold AUM
HF Horton Opportunity Fund 2 LP [2021-08-30] 5.7 M 11.1 M
Filed 2021-04-19 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets $5,000,001 - $25,000,000
HF Horton Capital Partners Fund LP [2020-01-06] 30.7 M 56.9 M
Filed 2022-04-27 (D/A) · Exemption 506(b) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Horton Freedom LP [2020-01-06] 4.8 M 19.8 M
Filed 2019-02-08 (D) · Exemption 506(b) · Minimum $25,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Sierra Capital Investments LP [2018-09-13] 5.7 M 8.3 M
Offered $5,675,000 · Filed 2017-11-21 (D) · Exemption 506(b) · Minimum $100,000 · Duration One year or less · Revenue Decline to Disclose
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 8.4
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 2 76.7
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 2.2
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 5 87.4
By Discretionary
Discretionary 5 87.4
Non-Discretionary 0 0.0
Total 5 87.4
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 87.4
Total 5 87.4
Form D Directors Role # Filings # Firms 2011 - 2026
James Dunn Jr Executive Officer 19 4
Darren Wallis Director 11 4
Joseph Manko Jr Executive Officer 5 2
Michael Howe Executive Officer 5 2
Horton Capital Partners LLC Executive Officer 3 2
Horton Capital Management LLC Executive Officer 3 2
David Achey Executive Officer 3 2
NA Horton Opportunity Partners 2 LLC Executive Officer 2 2
Manko Jr Joseph Executive Officer 2 2
Maplewood LLC Director 2 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001575444]
3 [0001575444]
4 [0001575444]
D [0001575444]
SC 13D [0001575444]
Form 13D/13G Filer Form 13D/13G Subject Filed
Horton Capital Management LLC Cynergistek Inc [2020-02-14]
Horton Capital Management LLC Safeguard Scientifics Inc [2018-01-29]
Firm Profile (Form ADV)
ServesInstitutional, Retail
Fund TypesHedge Fund
Form 3/4/5 Subject 2011 - 2026
Horton Capital Partners LLC
Manko Joseph M Jr
Horton Capital Management LLC
Horton Capital Partners Fund LP
Repro MED Systems Inc
Horton Freedom LP
Wireless Telecom Group Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Repro MED Systems Inc KRMD
Common Stock
2026-02-13 Other 750,000 $0.00
Repro MED Systems Inc KRMD
Common Stock
2026-02-13 Other 770,418 $0.00
Repro MED Systems Inc KRMD
Common Stock
2026-02-13 Other 282,347 $0.00
Repro MED Systems Inc KRMD
Common Stock
2026-02-13 Other 750,000 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-12-31 Grant 2,581 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-12-31 Gift 17,000 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-11-26 Other 41,000 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-09-30 Grant 3,916 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-06-30 Grant 4,189 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-05-20 Other 14,317 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-03-31 Grant 5,870 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-02-06 Other 16,187 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-01-21 Other 1,000,000 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-01-21 Other 1,000,000 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-01-21 Other 351,948 $0.00
Repro MED Systems Inc KRMD
Common Stock
2025-01-21 Other 1,000,000 $0.00
Repro MED Systems Inc KRMD
Common Stock
2024-12-31 Grant 3,937 $0.00
Repro MED Systems Inc KRMD
Common Stock
2024-09-30 Grant 5,454 $0.00
Repro MED Systems Inc KRMD
Common Stock
2024-07-24 Other 721,781 $0.00
Repro MED Systems Inc KRMD
Common Stock
2024-07-11 Grant 5,545 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com